Month: September 2022

Advanced device offers 72% larger samples, simplifies tissue retrieval, and enhances patient safety SOUTH JORDAN, Utah, Sept. 27, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of the TEMNO Elite™ Soft Tissue Biopsy System, the latest addition to Merit’s comprehensive portfolio of biopsy devices. Indicated for use in various soft tissue locations—such as liver, lung, lymph nodes, kidney, and other soft tissue suspect lesions—the single-use device is the result of Merit’s ongoing commitment to the advancement of biopsy procedures and complements a broader portfolio, which includes the TEMNO™, Achieve®, and Tru-Cut® families of devices. Biopsies are routinely performed to remove and examine tissue to assist...

On 14 September 2022, Tallinna Sadam held an investor day “In the winds of the future” at Tallinn Old City Harbour cruise terminal.   Tallinna Sadam would like to thank all participants. The recording of the event, both in Estonian and English translation, can be followed up on our youtube channel: https://www.youtube.com/user/portoftallinn and the presentation is available at the company’s web page: https://www.ts.ee/en/investor/presentations/ . Tallinna Sadam is one of the largest cargo- and passenger port complexes in the Baltic Sea region, which serves annually 10 million passengers and 20 million tons of cargo in average. In addition to passenger and freight services, Tallinna Sadam group also operates in shipping business via its subsidiaries – OÜ TS Laevad provides ferry services between the Estonian mainland and the largest islands,...

SAN DIEGO, Sept. 27, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the initiation of its Phase 3 global registrational study of zilovertamab, ZILO-301 (NCT05431179), for the treatment of patients with relapsed/refractory mantle cell lymphoma (MCL). The Company obtained its first Institutional Review Board (IRB) approval for the study and expects to promptly begin patient screening and enrollment. “The initiation of the first Phase 3 study of zilovertamab, ZILO-301, represents a key milestone for Oncternal, our partners, investors and patients with R/R MCL,” said James Breitmeyer, M.D., Ph.D., Oncternal’s President and CEO. “We are looking forward to opening between 50-100 sites across the globe...

Table 1 Table 1Figure 1 Figure 1Figure 2 Figure 2VANCOUVER, British Columbia, Sept. 27, 2022 (GLOBE NEWSWIRE) — Optimum Ventures Ltd. (“Optimum” or the “Company”) (TSXV: OPV) announces that the Company has received the gold and silver assays for select samples from BR, Usrula and Golden Summit zones located on the Harry property. Highlights of the sampling include:1.8 to 26.6 g/t Au and 282.9 to 1003.2 g/t Ag from 5 samples on the BR zone. 0.8 to 6.5 g/t gold and 131.3 to 208.1 g/t silver on the Ursula zone. 0.1 to 2.3 g/t Au and 470.3 to 5477.4 g/t Ag on the Golden Summit zone.This photo shows the relationship of the Swann zone to the BR zone. Optimum has also exposed a small portion of the Swann zone in about 2.5 m of overburden in preparation for further exploration based on the success of this year’s drilling.A...

Markham, Canada, Sept. 27, 2022 (GLOBE NEWSWIRE) — Visionary Education Technology Holdings Group Inc. (the “Company”) (NASDAQ:VEDU), a private education provider located in Canada, with partners in China, today announced that on September 23, 2022, the Company successfully completed the acquisition (the “Acquisition”) of two office buildings with a total of approximately 433,000 square feet of space at 95-105 Moatfield Drive, Toronto, which used to be the Canadian headquarters of IBM and Kraft Heinz. The Company completed the Acquisition for aggregate consideration of C$101 million. The Company plans to develop the two buildings to be the Visionary University Town, which is expected to build a solid foundation for its future development, expand its education programs, and greatly scale its business. The Company held...

SCOTTSDALE, Ariz., Sept. 27, 2022 (GLOBE NEWSWIRE) — Meritage Homes Corporation (NYSE: MTH), a leading U.S. homebuilder, plans to release the Company’s third quarter 2022 results on Wednesday, October 26, 2022 after the market closes. Management will host a conference call to discuss the results at 8:00 a.m. Pacific Daylight Time (11:00 a.m. Eastern Daylight Time) on Thursday, October 27, 2022. The call will be webcast with an accompanying slideshow, both available on the “Investor Relations” page of the Company’s website at https://investors.meritagehomes.com. A live webcast of the conference call will be available online at https://investors.meritagehomes.com. Telephone participants will be able to join by dialing in to 1-877-407-6951 US toll free or 1-412-902-0046 on the day of the call. A replay of the...

FortiAIOps builds on Fortinet’s rich history of developing artificial intelligence to deliver actionable network insights for self-optimizing management SUNNYVALE, Calif., Sept. 27, 2022 (GLOBE NEWSWIRE) — John Maddison, EVP of Products and CMO at Fortinet“Fortinet has spent the past decade maturing its AI and ML technology to analyze over 100 billion global security events a day covering all types of threats and attack techniques, which in turn informs over 1 billion daily security updates to Fortinet’s products. We’re continuing our commitment to AI innovation and automation by delivering AIOps capabilities across our robust portfolio of enterprise networking technology to help our customers proactively simplify Day 2 operations and improve uptime of the network. These latest enhancements are another significant step towards...

CAMBRIDGE, Mass., Sept. 27, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat at the Chardan’s 6th Annual Genetic Medicines Conference in New York City on Tuesday, October 4, 2022, at 3:15 p.m. ET. A live webcast of the presentation will be available on the Investor Relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. A replay of the presentation will be archived and available at that site for a limited time following the event. About Wave Life SciencesWave Life Sciences (Nasdaq: WVE) is a clinical-stage...

NEW YORK, Sept. 27, 2022 (GLOBE NEWSWIRE) — Elvictor Group, Inc. (OTC Pink: ELVG) (“Elvictor” or the “Company”) announced today that the Company will participate in the 12th Annual Capital Link Operational Excellence in Shipping Forum on Thursday, September 29, 2022 in Athens, Greece. Mr. Konstantinos Galanakis, CEO of the Company, will participate in a panel discussion on the Recruiting, Competence Building & The Welfare Of Seafarers. Geopolitical events are presenting a number of operational challenges to the shipping industry and its seafarers, who frequently find themselves on the front line. Seafarers are the backbone of the shipping industry – as we all witnessed during the Covid-19 pandemic – and the issues of recruitment, competence building, retention, and welfare remain core challenges as shipping companies...